SlideShare una empresa de Scribd logo
1 de 5
Descargar para leer sin conexión
Q3 FY07 Question & Answer
March 22, 2007

  1. What were some examples of major brands in the Consumer Foods segment posting sales growth for the
     quarter?

     Blue Bonnet
     Chef Boyardee
     DAVID
     Egg Beaters
     Hebrew National
     Hunt’s
     Marie Callender’s
     Manwich
     Orville Redenbacher’s
     PAM
     Rosarita
     Rotel
     Snack Pack
     Wolf
     VanCamp’s

      Sales for Slim Jim and Wesson were in line with last year’s amounts.

  2. What were some examples of major brands in the Consumer Foods segment posting sales declines for
     the quarter?

     ACT II
     Banquet
     Healthy Choice
     Kid Cuisine
     Knott’s Berry Farm
     LaChoy
     Libby’s
     Parkay
     Reddi-wip

  3. What were unit volume changes for the quarter in the Consumer Foods and Food and Ingredients
     segments?

     Consumer Foods volume declined 1%; excluding the peanut butter business and the impact of divested
     businesses in prior year results, volume increased 1%.

     Food and Ingredients volume increased 1%.

                                                Page 1 of 5
4. How much was total depreciation and amortization (all types) from continuing operations for the
   quarter?

   Approximately $91 million (versus approximately $78 million in Q3 2006)

5. How much was total depreciation and amortization (all types) from continuing operations for the fiscal
   year-to-date?

   Approximately $268 million (versus $227 million through Q3 2006)

6. How much were capital expenditures from continuing operations for the quarter?

   Approximately $147 million (versus approximately $54 million in Q3 2006)

7. How much were capital expenditures from continuing operations for the fiscal year-to-date?

   Approximately $258 million (versus $175 million through Q3 2006)

8. What was the net interest expense for the quarter?

   Approximately $56 million (versus approximately $69 million in Q3 2006)

9. What was the net interest expense for the fiscal year-to-date?

   Approximately $166 million (versus approximately $210 million through Q3 2006)

10. What was corporate expense for the quarter?

   Approximately $86 million, including $5 million of benefit from a legal settlement (versus
   approximately $171 million in Q3 2006, which included $73 million of expense from items that impact
   comparability).

11. How much did the company pay in dividends during the quarter?

   $91 million

12. How much did the company pay in dividends fiscal year-to-date?

   $276 million

13. What was the weighted average number of diluted shares outstanding for the quarter?

   507 million shares

14. What were the gross margins and operating margins for the quarter ($ amounts in millions, rounded)?

   Gross margin = gross profit* divided by net sales
   Gross margin = $775/$2,918 = 26.6%

   Operating margin = segment operating profit** divided by net sales

                                               Page 2 of 5
Operating margin = $411/$2,918 = 14.1%

   * Gross profit = net sales – costs of goods sold ($2,918 – $2,143 = $775)

   **See third-quarter segment operating results for a reconciliation of operating profit to income from
   continuing operations before income taxes and equity method investment earnings (loss). Income from
   continuing operations before income taxes and equity method investment earnings (loss), divided by net
   sales = $269/$2,918 = 9.2%.

15. What is included in the company’s net debt at the end of the quarter (in millions)?

                                                   Q3 FY07              Q3 FY06
   Total debt*                                      $3,480               $3,842
   Less: Cash on hand                               $ 497                $ 237
          Net debt total                            $2,983               $3,605

   * Total debt = notes payable, short-term debt, long-term debt, and subordinated debt.

16. What is the net debt to total capital ratio at quarter end?

   39% currently and 43% a year ago

   This ratio is defined as net debt divided by the sum of net debt plus shareholder equity. See question
   #15 for the components of net debt.

17. How much did the company contribute to its pension plans during the quarter and how much has the
    company contributed to its pension plans fiscal year-to-date?

   The company contributed approximately $106 million during the quarter, making the year-to-date
   approximately $170 million.

18. What was the effective tax rate for the quarter?

   During the quarter, the company revised its expected tax rate for fiscal 2007 to 35% from 36%,
   excluding items impacting comparability; this revision resulted in a 33% effective tax rate for the
   quarter which added approximately $0.01 benefit to current quarter EPS (shown as an item impacting
   comparability).

19. What is the projected tax rate for the next several quarters?

   The company plans for a tax rate of 35% on pretax earnings, excluding items that impact comparability.

20. What are the projected capital expenditures for fiscal 2007?

   In the range of $400 million

21. What is the expected net interest expense for fiscal 2007?

   Approximately $225 million

22. What was the impact of adopting FAS123R during the quarter?

                                                  Page 3 of 5
Expensing of stock options resulted in recognizing increased expense of approximately $6 million
   pretax.

23. Where were the third quarter’s restructuring charges classified within Consumer Foods?

   Cost of goods sold—approximately $18 million
   SG&A/other expense—approximately $2 million

24. Did the company repurchase any shares during the quarter?

   Yes, the company repurchased approximately 7.4 million shares of common stock during the quarter at a
   total cost of approximately $197 million. At quarter-end, the company had approximately $300 million
   of authorized repurchases remaining under its existing share repurchase program.

25. As reported in the earnings release and prior releases, what are the main items in the third-quarter fiscal
    2007 diluted EPS that will affect comparability with third-quarter fiscal 2006 diluted EPS?

    Summary of major items included in diluted EPS of $0.38           Third Quarter
    for the third quarter of fiscal 2007                                  FY07

    Expense related to restructuring program                                $0.03
    Benefit from a lower-than-normal tax rate                               $0.01
    Benefit due to a legal settlement                                       $0.01
    Income from discontinued operations                                     $0.01
    Costs related to peanut butter recall                                   $0.06

    Summary of major item included in diluted EPS of ($0.05) Third Quarter
    for the third quarter of fiscal 2006                         FY06

    Loss from discontinued operations largely due to impairment
                                                                            $0.24
    charges
    Expense related to restructuring charges                                $0.06
    Expense related to a note receivable                                    $0.06
    Expense reflecting the adjustment of a litigation reserve               $0.02
    Benefit from lower-than-normal tax rate                                 $0.02
    Impairment charges associated with an equity investment                 $0.02

26. Does the company have any comment on how the recent divestitures should impact SG&A cost
    reduction goals?

   The company is aggressively pursuing SG&A cost reductions, particularly focusing on costs that were
   associated with the recently divested businesses. As part of the divestiture agreements, the company is
   providing some transition services to the buyers; the company will therefore not significantly change all
   of the applicable SG&A activities or reduce the related costs until it stops providing the services. The
   buyers are reimbursing the company for these services, and the company considers the amount of the
   reimbursement to roughly represent amounts identified for cost reduction once the services and
   reimbursement have stopped. Excluding reimbursement for direct pass-through costs, buyer payment to

                                                 Page 4 of 5
ConAgra Foods during the fiscal 2007 third quarter was approximately $15 million for fixed-cost related
   items.

27. Given the changes to discontinued operations and other items in fiscal 2006 that occurred after the
    fourth quarter fiscal 2006 earnings release, what are the major items impacting EPS comparability for
    continuing operations in the fourth quarter of fiscal 2006?

Major Items Affecting Fourth-Quarter Fiscal 2006 EPS

Included in the $0.11 diluted EPS from Continuing Operations (EPS amounts rounded and after tax):
• Expense of $0.09 per diluted share, or $79 million pretax, for restructuring charges related to programs
   designed to reduce the company’s ongoing operating costs. These are classified as $44 million of
   expense within the Consumer Foods segment (Cost of Goods Sold of $15 million and SG&A expense of
   $29 million), $5 million of SG&A expense within the Food and Ingredients segment, and $30 million of
   SG&A expense within corporate.
• Expense of $0.04 per diluted share, or $36 million pretax, for a charge related to a note receivable,
   which is included within corporate.
• Expense of $0.05 per diluted share, or $24 million, resulting from asset impairment charges associated
   with an equity method investment, and classified within the results of equity method investment
   earnings (loss). There is no tax benefit related to these charges.
• Expense of $0.03 per diluted share, or $26 million pretax, for a charge related to early retirement of
   debt, which is included within corporate.
• Benefit of $0.04 per diluted share for a lower than normal tax rate.


Note on Forward-Looking Statements:
This document contains forward-looking statements within the meaning of the Private Securities Litigation
Reform Act of 1995. These statements are based on management’s current views and assumptions of
future events and financial performance and are subject to uncertainty and changes in circumstances. The
company undertakes no responsibility to update these statements. Readers of this document should
understand that these statements are not guarantees of performance or results. Many factors could affect
the company’s actual financial results and cause them to vary materially from the expectations contained in
the forward-looking statements. These factors include, among other things, future economic
circumstances, industry conditions, availability and prices of raw materials, product pricing, competitive
environment and related market conditions, operating efficiencies, the ultimate impact of the company’s
peanut butter recall, the company’s ability to execute its operating and restructuring plans, access to capital,
actions of governments and regulatory factors affecting the company’s businesses and other risks described
in the company’s reports filed with the Securities and Exchange Commission. The company cautions
readers not to place undue reliance on any forward-looking statements included in this document, which
speak only as of the date made.




                                                Page 5 of 5

Más contenido relacionado

La actualidad más candente

Q3%20FY08%20Q&A%20(Final)
Q3%20FY08%20Q&A%20(Final)Q3%20FY08%20Q&A%20(Final)
Q3%20FY08%20Q&A%20(Final)
finance21
 
ConAgra Q1Sept22-04
ConAgra Q1Sept22-04ConAgra Q1Sept22-04
ConAgra Q1Sept22-04
finance21
 
eastman kodak 2q 07mda
eastman kodak 2q 07mdaeastman kodak 2q 07mda
eastman kodak 2q 07mda
finance24
 
goodrich 4Q06_Slides
goodrich  4Q06_Slidesgoodrich  4Q06_Slides
goodrich 4Q06_Slides
finance44
 
merck 4Q07 Earnings Release
merck  	4Q07 Earnings Releasemerck  	4Q07 Earnings Release
merck 4Q07 Earnings Release
finance11
 
1Q06Transcriptprerecordcoments
1Q06Transcriptprerecordcoments1Q06Transcriptprerecordcoments
1Q06Transcriptprerecordcoments
finance22
 
United Health Group [PDF Document] Earnings Release
United Health Group [PDF Document] Earnings ReleaseUnited Health Group [PDF Document] Earnings Release
United Health Group [PDF Document] Earnings Release
finance3
 
walt disney Quarter 2004 4th
walt disney  Quarter 2004 4thwalt disney  Quarter 2004 4th
walt disney Quarter 2004 4th
finance7
 
Download Documentation Q4 2007 Exelon Corporation Earnings Conference Call
Download Documentation 	Q4 2007 Exelon Corporation Earnings Conference CallDownload Documentation 	Q4 2007 Exelon Corporation Earnings Conference Call
Download Documentation Q4 2007 Exelon Corporation Earnings Conference Call
finance14
 
Q3 Earnings Release
	Q3 Earnings Release	Q3 Earnings Release
Q3 Earnings Release
finance13
 
air products & chemicals fy 07 q2
air products & chemicals fy 07 q2air products & chemicals fy 07 q2
air products & chemicals fy 07 q2
finance26
 
clearchannel 289
clearchannel 289clearchannel 289
clearchannel 289
finance31
 
goodrich PresentBW3Q20004
goodrich  PresentBW3Q20004goodrich  PresentBW3Q20004
goodrich PresentBW3Q20004
finance44
 
ameriprise 4Q06_Release
ameriprise 4Q06_Releaseameriprise 4Q06_Release
ameriprise 4Q06_Release
finance43
 

La actualidad más candente (17)

Q3%20FY08%20Q&A%20(Final)
Q3%20FY08%20Q&A%20(Final)Q3%20FY08%20Q&A%20(Final)
Q3%20FY08%20Q&A%20(Final)
 
2Q_2007_PR
2Q_2007_PR2Q_2007_PR
2Q_2007_PR
 
ConAgra Q1Sept22-04
ConAgra Q1Sept22-04ConAgra Q1Sept22-04
ConAgra Q1Sept22-04
 
eastman kodak 2q 07mda
eastman kodak 2q 07mdaeastman kodak 2q 07mda
eastman kodak 2q 07mda
 
goodrich 4Q06_Slides
goodrich  4Q06_Slidesgoodrich  4Q06_Slides
goodrich 4Q06_Slides
 
merck 4Q07 Earnings Release
merck  	4Q07 Earnings Releasemerck  	4Q07 Earnings Release
merck 4Q07 Earnings Release
 
2 q18 earnings-presentation-vfinal
2 q18 earnings-presentation-vfinal2 q18 earnings-presentation-vfinal
2 q18 earnings-presentation-vfinal
 
1Q06Transcriptprerecordcoments
1Q06Transcriptprerecordcoments1Q06Transcriptprerecordcoments
1Q06Transcriptprerecordcoments
 
United Health Group [PDF Document] Earnings Release
United Health Group [PDF Document] Earnings ReleaseUnited Health Group [PDF Document] Earnings Release
United Health Group [PDF Document] Earnings Release
 
walt disney Quarter 2004 4th
walt disney  Quarter 2004 4thwalt disney  Quarter 2004 4th
walt disney Quarter 2004 4th
 
Download Documentation Q4 2007 Exelon Corporation Earnings Conference Call
Download Documentation 	Q4 2007 Exelon Corporation Earnings Conference CallDownload Documentation 	Q4 2007 Exelon Corporation Earnings Conference Call
Download Documentation Q4 2007 Exelon Corporation Earnings Conference Call
 
Q3 Earnings Release
	Q3 Earnings Release	Q3 Earnings Release
Q3 Earnings Release
 
air products & chemicals fy 07 q2
air products & chemicals fy 07 q2air products & chemicals fy 07 q2
air products & chemicals fy 07 q2
 
clearchannel 289
clearchannel 289clearchannel 289
clearchannel 289
 
AES 4Q 08ER
AES 4Q 08ERAES 4Q 08ER
AES 4Q 08ER
 
goodrich PresentBW3Q20004
goodrich  PresentBW3Q20004goodrich  PresentBW3Q20004
goodrich PresentBW3Q20004
 
ameriprise 4Q06_Release
ameriprise 4Q06_Releaseameriprise 4Q06_Release
ameriprise 4Q06_Release
 

Similar a ConAgra QAFY07Q3

ConAgra QAFY06Q3
ConAgra QAFY06Q3ConAgra QAFY06Q3
ConAgra QAFY06Q3
finance21
 
ConAgra Q3Mar04
ConAgra Q3Mar04ConAgra Q3Mar04
ConAgra Q3Mar04
finance21
 
ConAgra Q4Jul04
ConAgra Q4Jul04ConAgra Q4Jul04
ConAgra Q4Jul04
finance21
 
ConAgra%20Foods%20Q1%20FY09%20Q&A
ConAgra%20Foods%20Q1%20FY09%20Q&AConAgra%20Foods%20Q1%20FY09%20Q&A
ConAgra%20Foods%20Q1%20FY09%20Q&A
finance21
 
ConAgra Q2Dec04
ConAgra Q2Dec04ConAgra Q2Dec04
ConAgra Q2Dec04
finance21
 
ConAgra Q4Jun05
ConAgra Q4Jun05ConAgra Q4Jun05
ConAgra Q4Jun05
finance21
 
ConAgra Fiscal2008Q1_WrittenQA_Final
ConAgra Fiscal2008Q1_WrittenQA_FinalConAgra Fiscal2008Q1_WrittenQA_Final
ConAgra Fiscal2008Q1_WrittenQA_Final
finance21
 
CIT%202Q08%20RESULTS
  CIT%202Q08%20RESULTS  CIT%202Q08%20RESULTS
CIT%202Q08%20RESULTS
finance28
 
CIT%202Q08%20RESULTS
CIT%202Q08%20RESULTSCIT%202Q08%20RESULTS
CIT%202Q08%20RESULTS
finance28
 
raytheon Q4 Earnings Presentation
raytheon Q4 Earnings Presentationraytheon Q4 Earnings Presentation
raytheon Q4 Earnings Presentation
finance12
 
ameriprise 2Q06_Release
ameriprise 2Q06_Releaseameriprise 2Q06_Release
ameriprise 2Q06_Release
finance43
 
ConAgra QAFY06Q1
ConAgra QAFY06Q1ConAgra QAFY06Q1
ConAgra QAFY06Q1
finance21
 
raytheon Q4 Earnings Presentation
raytheon Q4 Earnings Presentationraytheon Q4 Earnings Presentation
raytheon Q4 Earnings Presentation
finance12
 
ameriprise NR_042208_1
ameriprise NR_042208_1ameriprise NR_042208_1
ameriprise NR_042208_1
finance43
 
CIT%201Q%202008%20Earnings%20-%20FINAL
CIT%201Q%202008%20Earnings%20-%20FINALCIT%201Q%202008%20Earnings%20-%20FINAL
CIT%201Q%202008%20Earnings%20-%20FINAL
finance28
 
CIT%201Q%202008%20Earnings%20-%20FINAL
CIT%201Q%202008%20Earnings%20-%20FINALCIT%201Q%202008%20Earnings%20-%20FINAL
CIT%201Q%202008%20Earnings%20-%20FINAL
finance28
 

Similar a ConAgra QAFY07Q3 (20)

ConAgra QAFY06Q3
ConAgra QAFY06Q3ConAgra QAFY06Q3
ConAgra QAFY06Q3
 
ConAgra Q3Mar04
ConAgra Q3Mar04ConAgra Q3Mar04
ConAgra Q3Mar04
 
ConAgra Q4Jul04
ConAgra Q4Jul04ConAgra Q4Jul04
ConAgra Q4Jul04
 
ConAgra%20Foods%20Q1%20FY09%20Q&A
ConAgra%20Foods%20Q1%20FY09%20Q&AConAgra%20Foods%20Q1%20FY09%20Q&A
ConAgra%20Foods%20Q1%20FY09%20Q&A
 
ConAgra Q2Dec04
ConAgra Q2Dec04ConAgra Q2Dec04
ConAgra Q2Dec04
 
ConAgra Q4Jun05
ConAgra Q4Jun05ConAgra Q4Jun05
ConAgra Q4Jun05
 
ConAgra Fiscal2008Q1_WrittenQA_Final
ConAgra Fiscal2008Q1_WrittenQA_FinalConAgra Fiscal2008Q1_WrittenQA_Final
ConAgra Fiscal2008Q1_WrittenQA_Final
 
CIT%202Q08%20RESULTS
  CIT%202Q08%20RESULTS  CIT%202Q08%20RESULTS
CIT%202Q08%20RESULTS
 
CIT%202Q08%20RESULTS
CIT%202Q08%20RESULTSCIT%202Q08%20RESULTS
CIT%202Q08%20RESULTS
 
raytheon Q4 Earnings Presentation
raytheon Q4 Earnings Presentationraytheon Q4 Earnings Presentation
raytheon Q4 Earnings Presentation
 
20180509 sauc q1 2018 teleconference slides final
20180509 sauc q1 2018 teleconference slides final20180509 sauc q1 2018 teleconference slides final
20180509 sauc q1 2018 teleconference slides final
 
ameriprise 2Q06_Release
ameriprise 2Q06_Releaseameriprise 2Q06_Release
ameriprise 2Q06_Release
 
ConAgra QAFY06Q1
ConAgra QAFY06Q1ConAgra QAFY06Q1
ConAgra QAFY06Q1
 
raytheon Q4 Earnings Presentation
raytheon Q4 Earnings Presentationraytheon Q4 Earnings Presentation
raytheon Q4 Earnings Presentation
 
Slides q3 2018 final
Slides q3 2018  final Slides q3 2018  final
Slides q3 2018 final
 
I-Bytes Retail & Consumer Goods Industry
I-Bytes Retail & Consumer Goods IndustryI-Bytes Retail & Consumer Goods Industry
I-Bytes Retail & Consumer Goods Industry
 
ameriprise NR_042208_1
ameriprise NR_042208_1ameriprise NR_042208_1
ameriprise NR_042208_1
 
Q3Mar05
Q3Mar05Q3Mar05
Q3Mar05
 
CIT%201Q%202008%20Earnings%20-%20FINAL
CIT%201Q%202008%20Earnings%20-%20FINALCIT%201Q%202008%20Earnings%20-%20FINAL
CIT%201Q%202008%20Earnings%20-%20FINAL
 
CIT%201Q%202008%20Earnings%20-%20FINAL
CIT%201Q%202008%20Earnings%20-%20FINALCIT%201Q%202008%20Earnings%20-%20FINAL
CIT%201Q%202008%20Earnings%20-%20FINAL
 

Más de finance21

ConAgra June92003Q&A
ConAgra June92003Q&AConAgra June92003Q&A
ConAgra June92003Q&A
finance21
 
ConAgra UAP10-03
ConAgra UAP10-03ConAgra UAP10-03
ConAgra UAP10-03
finance21
 
ConAgra DealClosing11-03
ConAgra DealClosing11-03ConAgra DealClosing11-03
ConAgra DealClosing11-03
finance21
 
ConAgra DealClosingb11-03
ConAgra DealClosingb11-03ConAgra DealClosingb11-03
ConAgra DealClosingb11-03
finance21
 
SharePurchase12-03
SharePurchase12-03SharePurchase12-03
SharePurchase12-03
finance21
 
ConAgra%20Foods%20Q4%20FY08%20Q&A
ConAgra%20Foods%20Q4%20FY08%20Q&AConAgra%20Foods%20Q4%20FY08%20Q&A
ConAgra%20Foods%20Q4%20FY08%20Q&A
finance21
 
ConAgra%20Foods%20Q2%20FY09%20Q&A
ConAgra%20Foods%20Q2%20FY09%20Q&AConAgra%20Foods%20Q2%20FY09%20Q&A
ConAgra%20Foods%20Q2%20FY09%20Q&A
finance21
 
CONAGRA Proxy 04
CONAGRA Proxy 04CONAGRA Proxy 04
CONAGRA Proxy 04
finance21
 
CONAGRA 10KA-04
CONAGRA 10KA-04CONAGRA 10KA-04
CONAGRA 10KA-04
finance21
 
CONAGRA 10KA-04
CONAGRA 10KA-04CONAGRA 10KA-04
CONAGRA 10KA-04
finance21
 
CONAGRA Proxy 05
CONAGRA Proxy 05CONAGRA Proxy 05
CONAGRA Proxy 05
finance21
 

Más de finance21 (11)

ConAgra June92003Q&A
ConAgra June92003Q&AConAgra June92003Q&A
ConAgra June92003Q&A
 
ConAgra UAP10-03
ConAgra UAP10-03ConAgra UAP10-03
ConAgra UAP10-03
 
ConAgra DealClosing11-03
ConAgra DealClosing11-03ConAgra DealClosing11-03
ConAgra DealClosing11-03
 
ConAgra DealClosingb11-03
ConAgra DealClosingb11-03ConAgra DealClosingb11-03
ConAgra DealClosingb11-03
 
SharePurchase12-03
SharePurchase12-03SharePurchase12-03
SharePurchase12-03
 
ConAgra%20Foods%20Q4%20FY08%20Q&A
ConAgra%20Foods%20Q4%20FY08%20Q&AConAgra%20Foods%20Q4%20FY08%20Q&A
ConAgra%20Foods%20Q4%20FY08%20Q&A
 
ConAgra%20Foods%20Q2%20FY09%20Q&A
ConAgra%20Foods%20Q2%20FY09%20Q&AConAgra%20Foods%20Q2%20FY09%20Q&A
ConAgra%20Foods%20Q2%20FY09%20Q&A
 
CONAGRA Proxy 04
CONAGRA Proxy 04CONAGRA Proxy 04
CONAGRA Proxy 04
 
CONAGRA 10KA-04
CONAGRA 10KA-04CONAGRA 10KA-04
CONAGRA 10KA-04
 
CONAGRA 10KA-04
CONAGRA 10KA-04CONAGRA 10KA-04
CONAGRA 10KA-04
 
CONAGRA Proxy 05
CONAGRA Proxy 05CONAGRA Proxy 05
CONAGRA Proxy 05
 

Último

[[Nerul]] MNavi Mumbai Honoreble Call Girls Number-9833754194-Panvel Best Es...
[[Nerul]] MNavi Mumbai Honoreble  Call Girls Number-9833754194-Panvel Best Es...[[Nerul]] MNavi Mumbai Honoreble  Call Girls Number-9833754194-Panvel Best Es...
[[Nerul]] MNavi Mumbai Honoreble Call Girls Number-9833754194-Panvel Best Es...
priyasharma62062
 
Call Girls in Yamuna Vihar (delhi) call me [🔝9953056974🔝] escort service 24X7
Call Girls in  Yamuna Vihar  (delhi) call me [🔝9953056974🔝] escort service 24X7Call Girls in  Yamuna Vihar  (delhi) call me [🔝9953056974🔝] escort service 24X7
Call Girls in Yamuna Vihar (delhi) call me [🔝9953056974🔝] escort service 24X7
9953056974 Low Rate Call Girls In Saket, Delhi NCR
 
Call Girls in Tilak Nagar (delhi) call me [🔝9953056974🔝] escort service 24X7
Call Girls in Tilak Nagar (delhi) call me [🔝9953056974🔝] escort service 24X7Call Girls in Tilak Nagar (delhi) call me [🔝9953056974🔝] escort service 24X7
Call Girls in Tilak Nagar (delhi) call me [🔝9953056974🔝] escort service 24X7
9953056974 Low Rate Call Girls In Saket, Delhi NCR
 

Último (20)

fundamentals of corporate finance 11th canadian edition test bank.docx
fundamentals of corporate finance 11th canadian edition test bank.docxfundamentals of corporate finance 11th canadian edition test bank.docx
fundamentals of corporate finance 11th canadian edition test bank.docx
 
Solution Manual For Financial Statement Analysis, 13th Edition By Charles H. ...
Solution Manual For Financial Statement Analysis, 13th Edition By Charles H. ...Solution Manual For Financial Statement Analysis, 13th Edition By Charles H. ...
Solution Manual For Financial Statement Analysis, 13th Edition By Charles H. ...
 
CBD Belapur((Thane)) Charming Call Girls📞❤9833754194 Kamothe Beautiful Call G...
CBD Belapur((Thane)) Charming Call Girls📞❤9833754194 Kamothe Beautiful Call G...CBD Belapur((Thane)) Charming Call Girls📞❤9833754194 Kamothe Beautiful Call G...
CBD Belapur((Thane)) Charming Call Girls📞❤9833754194 Kamothe Beautiful Call G...
 
Virar Best Sex Call Girls Number-📞📞9833754194-Poorbi Nalasopara Housewife Cal...
Virar Best Sex Call Girls Number-📞📞9833754194-Poorbi Nalasopara Housewife Cal...Virar Best Sex Call Girls Number-📞📞9833754194-Poorbi Nalasopara Housewife Cal...
Virar Best Sex Call Girls Number-📞📞9833754194-Poorbi Nalasopara Housewife Cal...
 
[[Nerul]] MNavi Mumbai Honoreble Call Girls Number-9833754194-Panvel Best Es...
[[Nerul]] MNavi Mumbai Honoreble  Call Girls Number-9833754194-Panvel Best Es...[[Nerul]] MNavi Mumbai Honoreble  Call Girls Number-9833754194-Panvel Best Es...
[[Nerul]] MNavi Mumbai Honoreble Call Girls Number-9833754194-Panvel Best Es...
 
Kopar Khairane Cheapest Call Girls✔✔✔9833754194 Nerul Premium Call Girls-Navi...
Kopar Khairane Cheapest Call Girls✔✔✔9833754194 Nerul Premium Call Girls-Navi...Kopar Khairane Cheapest Call Girls✔✔✔9833754194 Nerul Premium Call Girls-Navi...
Kopar Khairane Cheapest Call Girls✔✔✔9833754194 Nerul Premium Call Girls-Navi...
 
Pension dashboards forum 1 May 2024 (1).pdf
Pension dashboards forum 1 May 2024 (1).pdfPension dashboards forum 1 May 2024 (1).pdf
Pension dashboards forum 1 May 2024 (1).pdf
 
Seeman_Fiintouch_LLP_Newsletter_May-2024.pdf
Seeman_Fiintouch_LLP_Newsletter_May-2024.pdfSeeman_Fiintouch_LLP_Newsletter_May-2024.pdf
Seeman_Fiintouch_LLP_Newsletter_May-2024.pdf
 
Escorts Indore Call Girls-9155612368-Vijay Nagar Decent Fantastic Call Girls ...
Escorts Indore Call Girls-9155612368-Vijay Nagar Decent Fantastic Call Girls ...Escorts Indore Call Girls-9155612368-Vijay Nagar Decent Fantastic Call Girls ...
Escorts Indore Call Girls-9155612368-Vijay Nagar Decent Fantastic Call Girls ...
 
Bhubaneswar🌹Ravi Tailkes ❤CALL GIRLS 9777949614 💟 CALL GIRLS IN bhubaneswar ...
Bhubaneswar🌹Ravi Tailkes  ❤CALL GIRLS 9777949614 💟 CALL GIRLS IN bhubaneswar ...Bhubaneswar🌹Ravi Tailkes  ❤CALL GIRLS 9777949614 💟 CALL GIRLS IN bhubaneswar ...
Bhubaneswar🌹Ravi Tailkes ❤CALL GIRLS 9777949614 💟 CALL GIRLS IN bhubaneswar ...
 
Test bank for advanced assessment interpreting findings and formulating diffe...
Test bank for advanced assessment interpreting findings and formulating diffe...Test bank for advanced assessment interpreting findings and formulating diffe...
Test bank for advanced assessment interpreting findings and formulating diffe...
 
Collecting banker, Capacity of collecting Banker, conditions under section 13...
Collecting banker, Capacity of collecting Banker, conditions under section 13...Collecting banker, Capacity of collecting Banker, conditions under section 13...
Collecting banker, Capacity of collecting Banker, conditions under section 13...
 
Call Girls in Yamuna Vihar (delhi) call me [🔝9953056974🔝] escort service 24X7
Call Girls in  Yamuna Vihar  (delhi) call me [🔝9953056974🔝] escort service 24X7Call Girls in  Yamuna Vihar  (delhi) call me [🔝9953056974🔝] escort service 24X7
Call Girls in Yamuna Vihar (delhi) call me [🔝9953056974🔝] escort service 24X7
 
✂️ 👅 Independent Bhubaneswar Escorts Odisha Call Girls With Room Bhubaneswar ...
✂️ 👅 Independent Bhubaneswar Escorts Odisha Call Girls With Room Bhubaneswar ...✂️ 👅 Independent Bhubaneswar Escorts Odisha Call Girls With Room Bhubaneswar ...
✂️ 👅 Independent Bhubaneswar Escorts Odisha Call Girls With Room Bhubaneswar ...
 
logistics industry development power point ppt.pdf
logistics industry development power point ppt.pdflogistics industry development power point ppt.pdf
logistics industry development power point ppt.pdf
 
Q1 2024 Conference Call Presentation vF.pdf
Q1 2024 Conference Call Presentation vF.pdfQ1 2024 Conference Call Presentation vF.pdf
Q1 2024 Conference Call Presentation vF.pdf
 
GIFT City Overview India's Gateway to Global Finance
GIFT City Overview  India's Gateway to Global FinanceGIFT City Overview  India's Gateway to Global Finance
GIFT City Overview India's Gateway to Global Finance
 
Premium Call Girls Bangalore Call Girls Service Just Call 🍑👄6378878445 🍑👄 Top...
Premium Call Girls Bangalore Call Girls Service Just Call 🍑👄6378878445 🍑👄 Top...Premium Call Girls Bangalore Call Girls Service Just Call 🍑👄6378878445 🍑👄 Top...
Premium Call Girls Bangalore Call Girls Service Just Call 🍑👄6378878445 🍑👄 Top...
 
Call Girls in Tilak Nagar (delhi) call me [🔝9953056974🔝] escort service 24X7
Call Girls in Tilak Nagar (delhi) call me [🔝9953056974🔝] escort service 24X7Call Girls in Tilak Nagar (delhi) call me [🔝9953056974🔝] escort service 24X7
Call Girls in Tilak Nagar (delhi) call me [🔝9953056974🔝] escort service 24X7
 
falcon-invoice-discounting-unlocking-prime-investment-opportunities
falcon-invoice-discounting-unlocking-prime-investment-opportunitiesfalcon-invoice-discounting-unlocking-prime-investment-opportunities
falcon-invoice-discounting-unlocking-prime-investment-opportunities
 

ConAgra QAFY07Q3

  • 1. Q3 FY07 Question & Answer March 22, 2007 1. What were some examples of major brands in the Consumer Foods segment posting sales growth for the quarter? Blue Bonnet Chef Boyardee DAVID Egg Beaters Hebrew National Hunt’s Marie Callender’s Manwich Orville Redenbacher’s PAM Rosarita Rotel Snack Pack Wolf VanCamp’s Sales for Slim Jim and Wesson were in line with last year’s amounts. 2. What were some examples of major brands in the Consumer Foods segment posting sales declines for the quarter? ACT II Banquet Healthy Choice Kid Cuisine Knott’s Berry Farm LaChoy Libby’s Parkay Reddi-wip 3. What were unit volume changes for the quarter in the Consumer Foods and Food and Ingredients segments? Consumer Foods volume declined 1%; excluding the peanut butter business and the impact of divested businesses in prior year results, volume increased 1%. Food and Ingredients volume increased 1%. Page 1 of 5
  • 2. 4. How much was total depreciation and amortization (all types) from continuing operations for the quarter? Approximately $91 million (versus approximately $78 million in Q3 2006) 5. How much was total depreciation and amortization (all types) from continuing operations for the fiscal year-to-date? Approximately $268 million (versus $227 million through Q3 2006) 6. How much were capital expenditures from continuing operations for the quarter? Approximately $147 million (versus approximately $54 million in Q3 2006) 7. How much were capital expenditures from continuing operations for the fiscal year-to-date? Approximately $258 million (versus $175 million through Q3 2006) 8. What was the net interest expense for the quarter? Approximately $56 million (versus approximately $69 million in Q3 2006) 9. What was the net interest expense for the fiscal year-to-date? Approximately $166 million (versus approximately $210 million through Q3 2006) 10. What was corporate expense for the quarter? Approximately $86 million, including $5 million of benefit from a legal settlement (versus approximately $171 million in Q3 2006, which included $73 million of expense from items that impact comparability). 11. How much did the company pay in dividends during the quarter? $91 million 12. How much did the company pay in dividends fiscal year-to-date? $276 million 13. What was the weighted average number of diluted shares outstanding for the quarter? 507 million shares 14. What were the gross margins and operating margins for the quarter ($ amounts in millions, rounded)? Gross margin = gross profit* divided by net sales Gross margin = $775/$2,918 = 26.6% Operating margin = segment operating profit** divided by net sales Page 2 of 5
  • 3. Operating margin = $411/$2,918 = 14.1% * Gross profit = net sales – costs of goods sold ($2,918 – $2,143 = $775) **See third-quarter segment operating results for a reconciliation of operating profit to income from continuing operations before income taxes and equity method investment earnings (loss). Income from continuing operations before income taxes and equity method investment earnings (loss), divided by net sales = $269/$2,918 = 9.2%. 15. What is included in the company’s net debt at the end of the quarter (in millions)? Q3 FY07 Q3 FY06 Total debt* $3,480 $3,842 Less: Cash on hand $ 497 $ 237 Net debt total $2,983 $3,605 * Total debt = notes payable, short-term debt, long-term debt, and subordinated debt. 16. What is the net debt to total capital ratio at quarter end? 39% currently and 43% a year ago This ratio is defined as net debt divided by the sum of net debt plus shareholder equity. See question #15 for the components of net debt. 17. How much did the company contribute to its pension plans during the quarter and how much has the company contributed to its pension plans fiscal year-to-date? The company contributed approximately $106 million during the quarter, making the year-to-date approximately $170 million. 18. What was the effective tax rate for the quarter? During the quarter, the company revised its expected tax rate for fiscal 2007 to 35% from 36%, excluding items impacting comparability; this revision resulted in a 33% effective tax rate for the quarter which added approximately $0.01 benefit to current quarter EPS (shown as an item impacting comparability). 19. What is the projected tax rate for the next several quarters? The company plans for a tax rate of 35% on pretax earnings, excluding items that impact comparability. 20. What are the projected capital expenditures for fiscal 2007? In the range of $400 million 21. What is the expected net interest expense for fiscal 2007? Approximately $225 million 22. What was the impact of adopting FAS123R during the quarter? Page 3 of 5
  • 4. Expensing of stock options resulted in recognizing increased expense of approximately $6 million pretax. 23. Where were the third quarter’s restructuring charges classified within Consumer Foods? Cost of goods sold—approximately $18 million SG&A/other expense—approximately $2 million 24. Did the company repurchase any shares during the quarter? Yes, the company repurchased approximately 7.4 million shares of common stock during the quarter at a total cost of approximately $197 million. At quarter-end, the company had approximately $300 million of authorized repurchases remaining under its existing share repurchase program. 25. As reported in the earnings release and prior releases, what are the main items in the third-quarter fiscal 2007 diluted EPS that will affect comparability with third-quarter fiscal 2006 diluted EPS? Summary of major items included in diluted EPS of $0.38 Third Quarter for the third quarter of fiscal 2007 FY07 Expense related to restructuring program $0.03 Benefit from a lower-than-normal tax rate $0.01 Benefit due to a legal settlement $0.01 Income from discontinued operations $0.01 Costs related to peanut butter recall $0.06 Summary of major item included in diluted EPS of ($0.05) Third Quarter for the third quarter of fiscal 2006 FY06 Loss from discontinued operations largely due to impairment $0.24 charges Expense related to restructuring charges $0.06 Expense related to a note receivable $0.06 Expense reflecting the adjustment of a litigation reserve $0.02 Benefit from lower-than-normal tax rate $0.02 Impairment charges associated with an equity investment $0.02 26. Does the company have any comment on how the recent divestitures should impact SG&A cost reduction goals? The company is aggressively pursuing SG&A cost reductions, particularly focusing on costs that were associated with the recently divested businesses. As part of the divestiture agreements, the company is providing some transition services to the buyers; the company will therefore not significantly change all of the applicable SG&A activities or reduce the related costs until it stops providing the services. The buyers are reimbursing the company for these services, and the company considers the amount of the reimbursement to roughly represent amounts identified for cost reduction once the services and reimbursement have stopped. Excluding reimbursement for direct pass-through costs, buyer payment to Page 4 of 5
  • 5. ConAgra Foods during the fiscal 2007 third quarter was approximately $15 million for fixed-cost related items. 27. Given the changes to discontinued operations and other items in fiscal 2006 that occurred after the fourth quarter fiscal 2006 earnings release, what are the major items impacting EPS comparability for continuing operations in the fourth quarter of fiscal 2006? Major Items Affecting Fourth-Quarter Fiscal 2006 EPS Included in the $0.11 diluted EPS from Continuing Operations (EPS amounts rounded and after tax): • Expense of $0.09 per diluted share, or $79 million pretax, for restructuring charges related to programs designed to reduce the company’s ongoing operating costs. These are classified as $44 million of expense within the Consumer Foods segment (Cost of Goods Sold of $15 million and SG&A expense of $29 million), $5 million of SG&A expense within the Food and Ingredients segment, and $30 million of SG&A expense within corporate. • Expense of $0.04 per diluted share, or $36 million pretax, for a charge related to a note receivable, which is included within corporate. • Expense of $0.05 per diluted share, or $24 million, resulting from asset impairment charges associated with an equity method investment, and classified within the results of equity method investment earnings (loss). There is no tax benefit related to these charges. • Expense of $0.03 per diluted share, or $26 million pretax, for a charge related to early retirement of debt, which is included within corporate. • Benefit of $0.04 per diluted share for a lower than normal tax rate. Note on Forward-Looking Statements: This document contains forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995. These statements are based on management’s current views and assumptions of future events and financial performance and are subject to uncertainty and changes in circumstances. The company undertakes no responsibility to update these statements. Readers of this document should understand that these statements are not guarantees of performance or results. Many factors could affect the company’s actual financial results and cause them to vary materially from the expectations contained in the forward-looking statements. These factors include, among other things, future economic circumstances, industry conditions, availability and prices of raw materials, product pricing, competitive environment and related market conditions, operating efficiencies, the ultimate impact of the company’s peanut butter recall, the company’s ability to execute its operating and restructuring plans, access to capital, actions of governments and regulatory factors affecting the company’s businesses and other risks described in the company’s reports filed with the Securities and Exchange Commission. The company cautions readers not to place undue reliance on any forward-looking statements included in this document, which speak only as of the date made. Page 5 of 5